Juul bought an entire issue of a scholarly journal

Re:Juul bought an entire issue of a scholarly journal by elif on Thursday July 08, 2021 @11:09AM (#27772935)

See marijuana if you believe regulators will actually listen to a preponderance of evidence. FDA/pharma executives are a revolving door, and therefore concerned chiefly with the health of pharma rather than humans.

[ Parent | on HN ]

Re:Juul bought an entire issue of a scholarly journal by fragmede on Thursday July 08, 2021 @07:10PM (#27778735)

There are (AFAIK) 3 cannabis derived products that the FDA has approved. Given the large cost required to get a new patentable drug through the FDA, it doesn't come as a surprise that no one's willing to foot that bill.

What the DEA (a totally different governmental organization with different motivations and biases) thinks about marijuana is reprehensible, however.

[ Parent | on HN ]

Re:Juul bought an entire issue of a scholarly journal by elif on Friday July 09, 2021 @12:03AM (#27780364)

https://www.fda.gov/news-events/public-health-focus/fda-and-...

Exactly. They have approved 3 niche pharmaceutical industry replacements. Meanwhile they have kept their head in the sand regulating the 26 state cannabis industry, and we have no universal standards for contaminants, potency, etc. beyond state imposed regulations.

The CBD industry, which has been commercialized in most states, is also totally unregulated.

[ Parent | on HN ]

Re:Juul bought an entire issue of a scholarly journal by folli on Thursday July 08, 2021 @04:12PM (#27777037)

Recent developments (see aducanumab) have shown that the FDA mainly cares about safety but much less so about efficacy.

[ Parent | on HN ]